Minimal Residual Disease Testing Market Size, Share & Trends Report

Minimal Residual Disease Testing Market (2025 - 2030) Size, Share & Trends Analysis Report By Technology (NGS, PCR), By Cancer Type (Hematological Malignancy, Solid Tumors), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts

Market Segmentation

Minimal Residual Disease Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Flow Cytometry
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Others
Minimal Residual Disease Testing Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hematological Malignancy
  - Leukemia
  - Lymphoma
- Solid Tumors
Minimal Residual Disease Testing End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic and Research Institutes
- Diagnostics Laboratories
- Hospitals and Specialty Clinics
- Others
Minimal Residual Disease Testing Regional Outlook (Revenue, USD Million, 2018- 2030)
- North America
  - North America Minimal Residual Disease Testing Market, By Technology
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Sequencing (NGS)
    - Others
  - North America Minimal Residual Disease Testing Market, By Cancer Type
    - Hematological Malignancy
    - Leukemia
    - Lymphoma
    - Solid Tumors
  - North America Minimal Residual Disease Testing Market, By End Use
    - Academic and Research Institutes
    - Diagnostics Laboratories
    - Hospitals and Specialty Clinics
    - Others
  - U.S.
    - U.S. Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - U.S. Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - U.S. Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Canada
    - Canada Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Canada Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Canada Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Mexico
    - Mexico Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Mexico Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Mexico Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
- Europe
  - Europe Minimal Residual Disease Testing Market, By Technology
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Sequencing (NGS)
    - Others
  - Europe Minimal Residual Disease Testing Market, By Cancer Type
    - Hematological Malignancy
    - Leukemia
    - Lymphoma
    - Solid Tumors
  - Europe Minimal Residual Disease Testing Market, By End Use
    - Academic and Research Institutes
    - Diagnostics Laboratories
    - Hospitals and Specialty Clinics
    - Others
  - UK
    - UK Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - UK Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - UK Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Germany
    - Germany Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Germany Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Germany Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - France
    - France Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - France Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - France Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Spain
    - Spain Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Spain Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Spain Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Italy
    - Italy Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Italy Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Italy Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Denmark
    - Denmark Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Denmark Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Denmark Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Sweden
    - Sweden Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Sweden Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Sweden Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Norway
    - Norway Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Norway Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Norway Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
- Asia Pacific
  - Asia Pacific Minimal Residual Disease Testing Market, By Technology
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Sequencing (NGS)
    - Others
  - Asia Pacific Minimal Residual Disease Testing Market, By Cancer Type
    - Hematological Malignancy
    - Leukemia
    - Lymphoma
    - Solid Tumors
  - Asia Pacific Minimal Residual Disease Testing Market, By End Use
    - Academic and Research Institutes
    - Diagnostics Laboratories
    - Hospitals and Specialty Clinics
    - Others
  - Japan
    - Japan Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Japan Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Japan Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - China
    - China Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - China Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - China Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - India
    - India Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - India Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - India Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - South Korea
    - South Korea Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - South Korea Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - South Korea Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Australia
    - Australia Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Australia Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Australia Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Thailand
    - Thailand Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Thailand Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Thailand Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
- Latin America
  - Latin America Minimal Residual Disease Testing Market, By Technology
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Sequencing (NGS)
    - Others
  - Latin America Minimal Residual Disease Testing Market, By Cancer Type
    - Hematological Malignancy
    - Leukemia
    - Lymphoma
    - Solid Tumors
  - Latin America Minimal Residual Disease Testing Market, By End Use
    - Academic and Research Institutes
    - Diagnostics Laboratories
    - Hospitals and Specialty Clinics
    - Others
  - Brazil
    - Brazil Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Brazil Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Brazil Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Argentina
    - Argentina Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Argentina Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Argentina Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
- Middle East and Africa (MEA)
  - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By Technology
    - Flow Cytometry
    - Polymerase Chain Reaction (PCR)
    - Next Generation Sequencing (NGS)
    - Others
  - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By Cancer Type
    - Hematological Malignancy
    - Leukemia
    - Lymphoma
    - Solid Tumors
  - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By End Use
    - Academic and Research Institutes
    - Diagnostics Laboratories
    - Hospitals and Specialty Clinics
    - Others
  - South Africa
    - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Middle East and Africa (MEA) Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Saudi Arabia
    - Saudi Arabia Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Saudi Arabia Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Saudi Arabia Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - UAE
    - UAE Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - UAE Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - UAE Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others
  - Kuwait
    - Kuwait Minimal Residual Disease Testing Market, By Technology
      - Flow Cytometry
      - Polymerase Chain Reaction (PCR)
      - Next Generation Sequencing (NGS)
      - Others
    - Kuwait Minimal Residual Disease Testing Market, By Cancer Type
      - Hematological Malignancy
      - Leukemia
      - Lymphoma
      - Solid Tumors
    - Kuwait Minimal Residual Disease Testing Market, By End Use
      - Academic and Research Institutes
      - Diagnostics Laboratories
      - Hospitals and Specialty Clinics
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments